Amicus Therapeutics Inc (FOLD) — Cash Flow-to-Debt Ratio
Amicus Therapeutics Inc (FOLD) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of $16.25 Million could theoretically repay 0% of its total liabilities ($675.63 Million) in one year. Explore Amicus Therapeutics Inc (FOLD) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Amicus Therapeutics Inc Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Amicus Therapeutics Inc across 21 annual periods. Also explore Amicus Therapeutics Inc (FOLD) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Amicus Therapeutics Inc (2005–2025)
Year-by-year debt coverage analysis for Amicus Therapeutics Inc. For market capitalisation and broader financial context, see FOLD market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | $33.15 Million | $675.63 Million | ▲ +185.5% |
| 2024 | -0.06x | $-33.89 Million | $590.99 Million | ▲ +48.7% |
| 2023 | -0.11x | $-69.09 Million | $617.71 Million | ▲ +59.6% |
| 2022 | -0.28x | $-166.57 Million | $601.12 Million | ▲ +18.2% |
| 2021 | -0.34x | $-202.49 Million | $597.77 Million | ▲ +12.9% |
| 2020 | -0.39x | $-233.29 Million | $600.14 Million | ▲ +42.0% |
| 2019 | -0.67x | $-250.42 Million | $373.78 Million | ▲ +0.2% |
| 2018 | -0.67x | $-299.95 Million | $447.04 Million | ▲ +14.6% |
| 2017 | -0.79x | $-215.49 Million | $274.17 Million | ▼ -253.3% |
| 2016 | -0.22x | $-150.53 Million | $676.69 Million | ▼ -24.5% |
| 2015 | -0.18x | $-100.14 Million | $560.55 Million | ▲ +69.6% |
| 2014 | -0.59x | $-51.67 Million | $87.79 Million | ▼ -5.1% |
| 2013 | -0.56x | $-45.79 Million | $81.81 Million | ▲ +32.2% |
| 2012 | -0.83x | $-33.74 Million | $40.87 Million | ▲ +32.8% |
| 2011 | -1.23x | $-49.42 Million | $40.20 Million | ▼ -318.6% |
| 2010 | -0.29x | $-13.98 Million | $47.62 Million | ▲ +90.8% |
| 2009 | -3.20x | $-43.37 Million | $13.54 Million | ▼ -401.8% |
| 2008 | -0.64x | $-36.86 Million | $57.73 Million | ▼ -368.2% |
| 2007 | 0.24x | $15.19 Million | $63.80 Million | ▲ +196.4% |
| 2006 | -0.25x | $-33.89 Million | $137.16 Million | ▲ +12.1% |
| 2005 | -0.28x | $-18.12 Million | $64.50 Million | — |